LEO PHARMA A/S — Credit Rating and Financial Key Figures

LEO PHARMA A/S (CVR number: 56759514K) is a company from BALLERUP. The company reported a net sales of 12453 mDKK in 2024, demonstrating a growth of 9.3 % compared to the previous year. The operating profit percentage was poor at -9.2 % (EBIT: -1143 mDKK), while net earnings were -1776 mDKK. The profitability of the company measured by Return on Assets (ROA) was -4.9 %, which can be considered poor and Return on Equity (ROE) was -49.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 13.4 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. LEO PHARMA A/S's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.